Community Practice Connections: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient Care
WebcastFaculty
OVERVIEW
Community Practice Connections: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient Care is organized by Physicians Education Resource, LLC (PER) and will be held during Jun 30, 2017 - Jun 30, 2018.
The target audience for this medical event is directed toward nurses and other healthcare professionals with an interest in the treatment of lung cancers. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Overview :
Community Practice Connections: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient Care features a summary of clinical evidence guiding best practices in the treatment of patients with non–small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR) gene, as well as case-based discussions of adverse event management, compliance with oral therapies, and counseling of patients awaiting molecular test results. Interactive clinical vignettes are followed by short video interviews with leading experts in the management of patients with EGFR mutation-positive NSCLC. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting by nursing professionals engaged in the care of patients with lung cancers.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Explain current and emerging testing platforms in the context of emerging methods to overcome barriers associated with tumor biopsies in the field of lung cancer treatment
• Detail key counseling points to address with patients with lung cancer who are awaiting results from tumor tissue testing
• Describe current and emerging evidence concerning the use of EGFR-targeted strategies in frontline and relapsed advanced non–small-cell lung cancer (NSCLC) disease settings
• Apply best nursing practices to counsel patients with advanced NSCLC concerning the prevention, mitigation, and management of treatment-related toxicities
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward nurses and other healthcare professionals with an interest in the treatment of lung cancers. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Overview :
Community Practice Connections: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient Care features a summary of clinical evidence guiding best practices in the treatment of patients with non–small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR) gene, as well as case-based discussions of adverse event management, compliance with oral therapies, and counseling of patients awaiting molecular test results. Interactive clinical vignettes are followed by short video interviews with leading experts in the management of patients with EGFR mutation-positive NSCLC. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting by nursing professionals engaged in the care of patients with lung cancers.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Explain current and emerging testing platforms in the context of emerging methods to overcome barriers associated with tumor biopsies in the field of lung cancer treatment
• Detail key counseling points to address with patients with lung cancer who are awaiting results from tumor tissue testing
• Describe current and emerging evidence concerning the use of EGFR-targeted strategies in frontline and relapsed advanced non–small-cell lung cancer (NSCLC) disease settings
• Apply best nursing practices to counsel patients with advanced NSCLC concerning the prevention, mitigation, and management of treatment-related toxicities
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links